光滑 发表于 2025-3-26 22:45:19

http://reply.papertrans.cn/89/8849/884873/884873_31.png

archetype 发表于 2025-3-27 02:22:13

http://reply.papertrans.cn/89/8849/884873/884873_32.png

Ige326 发表于 2025-3-27 05:51:47

http://reply.papertrans.cn/89/8849/884873/884873_33.png

TOXIC 发表于 2025-3-27 11:34:34

Itshak Tkach,Tim Blackwellecretory profile of GH in both sexes of mice and specifically to masculinize GH secretion, however our data challenge the concept that a typical masculinized profile of GH pulsatility or masculinized liver is necessary for the greater somatic growth characteristics of male compared to female animals

browbeat 发表于 2025-3-27 16:03:54

John Biechele-Speziale,William Raymer,Vincent G. Duffyecretory profile of GH in both sexes of mice and specifically to masculinize GH secretion, however our data challenge the concept that a typical masculinized profile of GH pulsatility or masculinized liver is necessary for the greater somatic growth characteristics of male compared to female animals

Engaged 发表于 2025-3-27 19:38:07

http://reply.papertrans.cn/89/8849/884873/884873_36.png

G-spot 发表于 2025-3-27 22:34:26

http://reply.papertrans.cn/89/8849/884873/884873_37.png

讥笑 发表于 2025-3-28 02:27:40

Ran Shneor,Sigal Berman in our insight into the biology of somatostatin and its receptor subtypes, and has led to the design and development of subtype-selective peptide and non-peptide agonists and antagonists. Significant progress 978-1-4419-5440-4978-1-4020-8033-3Series ISSN 1566-0729

有权威 发表于 2025-3-28 10:11:10

Hendri Sutrisno,Chao-Lung Yang in our insight into the biology of somatostatin and its receptor subtypes, and has led to the design and development of subtype-selective peptide and non-peptide agonists and antagonists. Significant progress 978-1-4419-5440-4978-1-4020-8033-3Series ISSN 1566-0729

不能妥协 发表于 2025-3-28 11:16:57

http://reply.papertrans.cn/89/8849/884873/884873_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Systems Collaboration and Integration; See Past and Future Chin-Yin Huang,Sang Won Yoon Conference proceedings 2023 The Editor(s) (if appl